UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices)
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01. | Other Events. |
On July 28, 2025, Community Health Systems, Inc. (the “Company”) announced that CHS/Community Health Systems, Inc. (the “Issuer”), its wholly owned subsidiary, announced and priced an offering of $1,790 million aggregate principal amount of 9.750% Senior Secured Notes due 2034 (the “2034 Notes”). The size of the offering was increased by $290 million aggregate principal amount subsequent to the initial announcement of the proposed offering. The Issuer intends to use the net proceeds of the sale of the 2034 Notes to refinance its outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”) through a tender offer and, if applicable, a redemption. Copies of the press releases announcing the launch and pricing of the offering of the 2034 Notes are attached hereto as Exhibits 99.1 and 99.2 and are incorporated herein by reference.
In addition, on July 28, 2025, the Company issued press releases announcing that the Issuer has commenced a cash tender offer for any and all of its outstanding 2027 Notes. The size of the tender offer was increased by $287 million aggregate principal amount subsequent to its launch. Copies of the press releases relating to the tender offer are attached hereto as Exhibits 99.3 and 99.4 and are incorporated herein by reference.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
The following exhibit is filed herewith:
| 99.1 | Press Release of Community Health Systems, Inc., dated July 28, 2025 | |
| 99.2 | Press Release of Community Health Systems, Inc., dated July 28, 2025 | |
| 99.3 | Press Release of Community Health Systems, Inc., dated July 28, 2025 | |
| 99.4 | Press Release of Community Health Systems, Inc., dated July 28, 2025 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: July 28, 2025 | COMMUNITY HEALTH SYSTEMS, INC. (Registrant) | |||||
| By: | /s/ Kevin J. Hammons | |||||
| Kevin J. Hammons President and Chief Financial Officer (principal | ||||||